The trend toward full-service outsourcing has reached a peak in the French medical sector by late 2025, as biotech and pharmaceutical companies increasingly seek "end-to-end" partnerships with research providers. These alliances allow sponsors to delegate the entire clinical trial process—from protocol development and site selection to data management and final regulatory...